United Therapeutics Corporation shares owned by Morgan Stanley
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $145M | 412k | 352.84 |
| 2024-09-30 | $144M | 402k | 358.35 |
| 2024-06-30 | $257M | 807k | 318.55 |
| 2024-03-31 | $123M | 536k | 229.72 |
| 2023-12-31 | $101M | 460k | 219.89 |
| 2023-09-30 | $80M | 354k | 225.87 |
| 2023-06-30 | $68M | 309k | 220.80 |
| 2022-12-31 | $108M | 389k | 278.09 |
| 2022-06-30 | $81M | 345k | 235.77 |
| 2022-03-31 | $69M | 382k | 179.41 |
| 2021-06-30 | $23M | 130k | 179.97 |
| 2020-12-31 | $7.0M | 46k | 151.60 |
| 2020-09-30 | $2.5M | 25k | 100.96 |
| 2020-06-30 | $2.1M | 17k | 121.09 |
| 2020-03-31 | $2.7M | 28k | 94.88 |
| 2019-12-31 | $14M | 154k | 88.09 |
| 2019-09-30 | $5.1M | 63k | 81.52 |
| 2019-03-31 | $19M | 161k | 117.39 |
| 2018-12-31 | $21M | 189k | 108.89 |
| 2018-09-30 | $31M | 244k | 127.88 |
| 2018-06-30 | $25M | 223k | 113.14 |
| 2018-03-31 | $18M | 155k | 112.36 |
| 2017-12-31 | $26M | 174k | 147.95 |
| 2017-03-31 | $88M | 650k | 135.76 |
| 2016-12-31 | $65M | 455k | 142.38 |
| 2016-09-30 | $43M | 362k | 117.95 |
| 2016-06-30 | $41M | 396k | 103.03 |
| 2016-03-31 | $37M | 340k | 110.00 |
| 2015-12-31 | $51M | 322k | 157.89 |
| 2015-09-30 | $39M | 298k | 131.21 |
| 2015-06-30 | $50M | 285k | 173.91 |
| 2014-12-31 | $42M | 327k | 129.48 |
| 2014-09-30 | $31M | 238k | 128.81 |
| 2014-06-30 | $31M | 346k | 88.51 |
| 2014-03-31 | $36M | 302k | 117.65 |
| 2013-12-31 | $23M | 201k | 113.08 |
| 2013-09-30 | $14M | 181k | 78.86 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation